Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy

Egyptian Liver Journal

Table 5 AFP and sCD163 in recurrent and eradicated HCC cases pre- and post-locoregional intervention

Variable	Recurrent HCC cases (n=6)	Eradicated HCC cases (n=30)	p
AFP (ng/ml)
Pre-intervention			0.832^a
Median (IQR)	356 (232.5–502.5)	305 (138.5–742.5)	0.832^a
Post-intervention
Median (IQR)	365 (235.8–1999.8)	249 (182–634)	0.279^a
p	0.832^b	0.279^b	0.279^a
sCD163 (mg/L)
Pre-intervention			< 0.001^c
Mean±SD	8.4±0.4	6.1±1.4	< 0.001^c
Post-intervention
Mean±SD	10.3±1.6	2.3±1.4	< 0.001^c
p	0.022^d	< 0.001^d	< 0.001^c